• Western blot analysis of the lysates from HeLa cells using DHX8 antibody.
  • Western blot analysis of various cells using DDX8 Polyclonal Antibody diluted at 1:500 cells nucleus extracted by Minute TM Cytoplasmic and Nuclear Fractionation kit (SC-003, Inventbiotech, MN, USA).

Anti-DHX8 antibody (391-440 aa) (STJ92683)

SKU:
STJ92683

Current Stock:
Host: Rabbit
Applications: WB/ELISA
Reactivity: Human/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-ATP-dependent RNA helicase DHX8 (391-440 aa) is suitable for use in Western Blot and ELISA research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-1:2000
ELISA 1:5000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: DHX8
Gene ID: 1659
Uniprot ID: DHX8_HUMAN
Immunogen Region: 391-440 aa
Specificity: DDX8 Polyclonal Antibody detects endogenous levels of DDX8 protein.
Immunogen: The antiserum was produced against synthesized peptide derived from the human DHX8 at the amino acid range 391-440
Function Involved in pre-mRNA splicing as component of the spliceosome. Facilitates nuclear export of spliced mRNA by releasing the RNA from the spliceosome.
Protein Name Atp-Dependent Rna Helicase Dhx8
Deah Box Protein 8
Rna Helicase Hrh1
Database Links Reactome: R-HSA-72163
Cellular Localisation Nucleus
Alternative Antibody Names Anti-Atp-Dependent Rna Helicase Dhx8 antibody
Anti-Deah Box Protein 8 antibody
Anti-Rna Helicase Hrh1 antibody
Anti-DHX8 antibody
Anti-DDX8 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance